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Objectives: to analyse the hospital costs and benefits of screening older males for abdominal aortic aneurysm (AAA).
Methods and material: in 1994 a hospital-based screening trial of 12 658 65–73-year-old males was started. AAA
>5 cm were referred for surgery. The remaining AAA were offered annual scans. Those with aortic ectasia were rescreened
at 5 yearly intervals. AAA-operations and hospital AAA-related deaths were researched. The costs of screening, surveillance,
and treatment were also registered.
Results: the attendance rate was 76%; of whom 191 (4.0%) had AAA. Mean observation time was 5.13 years. Sixty in
the screened and 41 in the control group were operated (p=0.06), of which 7 and 27 respectively were operated as an
emergency (p<0.001), and 6 and 19 respectively died due to AAA (p=0.009). The costs per scan were 83.50 DKK,
81 400 DKK per emergency operation (71 485 DKK after screening), and 117 000 DKK per emergency operation. The
cost per prevented hospital death was 67 855 DKK, equivalent to approximately life year saved approx. 7540 DKK
(GBP1=12 DKK).
Conclusion: screening appears to reduce hospital AAA mortality and to be cost-effective.
Key Words: Randomised controlled trial; Mass screening; Abdominal aortic aneurysm; Costs; Benefits; Effectiveness.
Material and MethodIntroduction
Study populationIn spite of increased numbers of elective operations
for abdominal aortic aneurysms (AAA), the sex- and
The personal identification number, name, and ad-age standardised mortality of ruptured AAA con-
dresses of all 12 658 65–73 year old males were pro-tinued to increase.1–4 Screening for AAA appears to
vided by the health department of the county fromfulfil the recommendation of WHO,5 the council of
1994–98. After randomisation, 6319 acted as controls,Europe6 and national health authorities:7 specifically,
while 6339 were invited for an abdominal ultra-ultrasonography is sensitive, specific, fast and in-
sonographic scan at their regional hospital. Ap-expensive,1 and patient acceptance rates are high.1,8–11
pointments were made at 5 min intervals betweenFurthermore, those at greatest risk appear mmore
9.00 a.m. and 3.30 p.m. 3 days a week.likely to attend and so benefit.12–16
The invitation allowed for change of the ap-Despite this, the cost-effect of scanning remains
pointment or refusal to attend. Non-responders werecontroversial.17–19 The only randomised clinical trial
reinvited with an interval of 3 per 5 min. Fasting wassuggests that AAA mortality may be reduced by 50%.10
not recommended, and transport to the hospital wasIn order to examine costs and benefits of AAA screen-
not provided.ing, a randomised screening trial, involving all 65–73
A doctor and a nurse, specially trained in ultra-old males in the County of Viborg, Denmark, was set
sonography, alternated between organising the scansup in 1994.
and performing the scans. The B-mode scans were
carried out with a small Phillips SDR 1550 with linear
4 MHz transducer and calliper light pen.
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Baseline assessment Primary outcome measures were; AAA specific
deaths, numbers of operations, (total, elective and
The infrarenal aorta was first visualised antero- emergency), numbers of hospital deaths caused by
AAA, and the costs per prevented hospital deaths. Itposteriorly in its entire length. Its anteroposteriorly
(AP) and transversely (T) diameters were measured was not possible to collect data on AAA deaths outside
hospital. The costs for screening and surveillance wasat their maximal sizes. In the absence of AAA or focal
dilatation, the measurements were carried out just registered prospectively the first year of the trial. The
equipment was written off during three years.20 Theabove the bifurcation. The aorta was then scanned
proximally up to the left renal vein, where the AP indirect costs were calculated from questionnaires of
all 389 65 year old men attending screening in 1998.21and T were measured. If the vein was not seen, the
measurements were carried out as proximal as In order to calculate hospital costs, a random sample
of 100 AAA operation performed on Viborg Hospitalpossible.
from 1996–98.22,23 These records were used to estimate
the costs of treatment using the Activity Based Costing
concept.24 Operation costs were based on the existing
Intervention 1998 prices. Overheads for administration, heating,
electricity, rent, discount, and writing off the equip-
All living men in Viborg County born in 1921–33 ment were incorporated into the bed-price. Other in-
entered the study at its initiation or as they became direct costs were not included. Preoperative
65 years old. The intervention was initiated at the day evaluation, and postoperative cost were also costed.
of the study inclusion. Men were randomly assigned Admissions over 38 days were excluded because only
in a proportion 1:1 to receive offer of screening or the average course is relevant according to the DRG-
matching controls. The intervention was initiated at principles.
the day of study inclusion. No exclusions were made.
Statistical analyses
Assignment of intervention
Analyses were performed on intention to treat basis.
The individual patient was the unit of randomisation. Chi square tests with calculation of relative risks (RR),
The allocation schedule was performed by use of Epi6- odds ratios (OR) with 95% confidence limits was per-
Info. formed by EPI info 6.0.
Follow-up Ethics
An AAA was defined as having an infrarenal aortic The trial was approved by the local scientific ethics
diameter of 3 cm or more. Patients with an AAA committee and reported to the data protection
were invited to consult the doctor for information and authorities.
examination on the fourth day. AAAs of 5 cm or more
were referred to a vascular surgeon. The remaining
AAAs were offered yearly follow-up examinations, to
Resultscheck for any expansion. After 5 years, 248 men with
an initial ectatic aorta were offered rescreening.16
Overall, 12 658 men were included, mean age 67.5
years (Fig. 1), who have been followed for an average
of 5.13 years. No differences in observation length and
age at inclusion were observed between the screenedOutcome measure(s)
group and the control group. Of the 6339 men invited
for screening, 4843 attended (76%). Of these, 191 (4%)Hospital diagnoses of ruptured AAA, AAA- op-
erations and peroperative deaths for AAA in the had an AAA. Twenty-four of the 191 (0.5%) patients
had an AAA above 5 cm in diameter were referred forscreening group and in the control group were re-
gistered prospectively from 1st April 1994 to 31st surgery. During follow-up another 51 were referred
for surgery. Of the men referred for surgery, 7 areMarch 2001.
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group and the control group are calculated in Table
2. The total difference in costs between the two groups
were 882 125 DKK (1.3 million if indirect costs are
included), which corresponds to 140 and 205 DKK per
invited person, respectively. The cost per prevented
hospital death of AAA was 67 855 DKK, or 100 607
DKK if indirect costs are included. Assuming that men
surviving an operation for AAA only live nine years
(80% of the expected survival of an age-matched con-
trol population), the costs per life year saved due to
the presentation of a hospital AAA-related death are
7540 DKK (or 11 729 DKK including the indirect costs).
However, we have previously demonstrated that only
half of those experiencing a ruptured AAA in Viborg
County reaches operation.2 In all, 4 and 17 experienced
operation for ruptured AAA in the screening and
control group, respectively. Consequently, 4 and 17
more ruptures must be expected in the screeningFig. 1. Flow sheet of a randomised screening trial of 12 658 65–73-
and control group, respectively. Since they were notyear-old men in Viborg County, Denmark, for abdominal aortic
aneurysm (AAA). R-AAA: Ruptured abdominal aortic aneurysm. operated, they must have died. So in all, 10 and 36
S-AAA: Symptomatic, non-ruptured abdominal aortic aneurysm
must be assumed to have died due to AAA in theoperated acutely. ∗: AAA related deaths.
screening and control group respectively. Thus, 26
saved lives must be expected.
waiting for an operation, 5 had renal artery in- The estimated cost per life saved is then 33 928 DKK
volvement, 3 refused operation, 5 had a relative con- (3770 DKK per life year saved). If the existing DRG-
traindication for operation and are observed further tariffs were used, the figure would be 6123 DKK perbut will probably only be offered operation if the AAA
saved living year.exceeds 6 cm in diameter, and 2 died before operation
Table 2 shows a sensitivity analysis which varies thecould be performed, one of them due to ruptured
peroperative mortality of elective operations between 4AAA because the operation had temporary been can-
and 6%, and 40% to 60% concerning acute operationscelled due to acute myocardial infarction, the other due
with ruptured AAA. The costs per estimated savedto ruptured iliac aneurysms. In all, 60 were operated in
living years range from 4543 to 5548 DKK. In 1999 thethe screening group including those refusing screening
peroperative mortality rates of elective operations andcompared with 41 in the control group (p>0.05), but
acute surgery because of rupture were 4% and 49%,only 7 in the screening group compared with 27 in
respectively.25 The cost effectiveness of such mortalitythe control were performed as an emergency (p<0.001)
rates would be 4906 DKK. Table 2 also shows a sensi-(Table 1). Thus, the frequency of emergency operations
tivity analysis of varying the costs of the operationswas significantly reduced by 74% (95% CI: 54–89%) in
with the observed interquartiles. The costs per es-the screening group. No AAA operations were carried
timated saved living year range from 10 103 to−15 548out outside the county.
DKK – e.g. saved costs.In all died 6 of AAA at the hospitals in the screening
If the results from Tables 2 and 3 are merged, thegroup compared to 19 in the control group (p<0.01).
less cost effective combination would be a peroperativeConsequently, screening reduced the hospital mor-
mortality of elective and acute operations of 6 andtality of AAA by about 68% (41–89%). The peroperative
40%, respectively, combined with 25% higher costsmortality of elective, emergency operations without
of elective operation, and 25% lower costs of acuterupture, and acute operations with rupture was 6%
operations. The costs per estimated saved living year(2–15%), 23% (5–54%), and 66% (43–85%), respectively.
would then be 14 860 DKK. The best cost effectiveThe costs were 83.50 DKK per scan (GBP1=approx.
combination would be a peroperative mortality of12 DKK), and 75 DKK in indirect costs. The costs of a
elective and acute operations of 4% and 60%, re-elective operation was 71 485 DKK in cases diagnosed
spectively, combined with 25% lower costs of electiveby screening and 81 400 DKK in incidentally diagnosed
operation, and 25% higher costs of acute operations.cases, and 117 000 DKK for an emergency operation.
The costs would then be −14 860 DKK per estimatedThe total costs for screening, surveillance, pre-
operatively evaluation, and operation in the screening saved living year.
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Table 1. Benefits of screening 65–73 year old men for abdominal aortic aneurysms.
Screened Controlled Statistics Difference p-value
Totally operated Y 60 41 OR=1.46 +51% 0.05980
(0.96–2.23)
N 6279 6278 RR=1.23 (32–64%)
(0.97–1.56)
Elective operated Y 53 14 OR=3.80 +278% 0.00001
(2.03–7.21)
N 6286 6305 RR=2.40 (265–291%)
(1.50–3.82)
Acutely operated Y 7 27 OR=0.26 −74% 0.00057
(0.10–0.62)
N 6332 6292 RR=0.63 (54–89%)
(0.53–0.75)
Ruptured AAA Y 6 20 OR=0.30 −70% 0.00584
(0.11–0.78)
N 6333 6299 RR=0.46 (46–88%)
(0.23–0.93)
Hospital deaths Y 6 19 OR=0.31 −68% 0.00912
(0.11–0.90)
N 6333 6300 RR=0.48 (41–89%)
(0.24–0.86)
Table 2. Hospital costs and benefits of screening 65–73 year old men for abdominal aortic aneurysms.
Prize per piece Screening Screening costs Controls Control costs
n (DKK) n (DKK)
Screening 83 4843 404 474
Surveillance 83 585 48 847
Rescreening 83 248 20 708
Elective1 71 485/81 400 53 3 788 696 14 1 139 600
(11.812)
Acute operations 117 000 7 769 944.00 27 3 159 000
(41.231)
Total 5 180 725 4 298 600
+indirect costs 75 5677 5 606 500 4 298 600
Difference 882 125
+indirect costs 1 307 900
Numbers Costs Costs incl.
n (DKK) indirect costs
(DKK)
Costs per prevented hospital deaths 13 67 855 100 607
Costs per estimated saved lives2 26 33 927 50 303
Costs per saved living years (prevented hospital deaths)3 9×13 7539 11 178
Costs per estimated saved living years4 9×26 3 769 5589
GBP1=approx. 12 DKK, 1$=approx. 8.00 DKK, 1 Euro=approx. 7.50 DKK.
Interquartiles are noted in parentheses.
1 Electively operated screening diagnosed AAA=71 485 DKK.
Electively operated randomly diagnosed AAA=81 400 DKK.
2 Assuming 50% of cases with ruptured AAA reaches operation (see Fig. 1).
3 Assuming men surviving operation for AAA lives in average 9 years.
4 Assuming men surviving operation for AAA lives in average 9 years and 50% of cases with ruptured AAA reaches
operation.
Discussion selection bias seems unlikely. Screening for AAA re-
duced the frequency of acute operations by 74%, and
Since all in the age group were recruited, no exclusions AAA-related hospital mortality by 68%. The costs per
prevented hospital AAA-related death were aboutwere made, and average observation time and age
was similar in the screening group and control group, 67 855 DKK. Consequently, the cost per life year saved
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Table 3. Sensitivity analyses of the estimated saved living years by varying peroperative mortality rates
of elective surgery and acute operations due to ruptured abdominal aortic aneurysms, and by varying
the interquartiles of the observed costs of elective and acute operations. Costs including the indirect
costs are listed in parentheses.
Peroperative mortality of elective surgery
Peroperative mortality 4% 5% 6%
of rupture
40% 5334 (7908) 5425 (8044) 5548 (8221)
50% 4906 (7274) 4984 (7389) 5041 (7539)
60% 4543 (6735) 4609 (6833) 4695 (6961)
Costs of elective surgery
Costs of acute surgery −25% Median +25%
−25% 3413 (5232) 5552 (7331) 10 103 (11 933)
Median 2337 (4157) 3770 (5589) 5326 (7136)
+25% −15 548 (−13 729) −2203 (−384) 2011 (3830)
was probably about 7540 DKK.26 These expenses seem predict these cases with an acceptable high sensitivity
and specificity seems potential.28–31 Finally, an efficientquite modest compared to other health activities.
Some costs were not included into the analysis. For anti-inflammatory32,33 or antibiotic treatment may be
possible.34,35 Such developments would reduces theexample, if people in this age group are saved from
an AAA-related death, they may develop other dis- psychological side effects but optimal control intervals
are at present the only possibility to do so. AAAseases with corresponding health care costs.
We also choose to leave out discounting because if sized 3–3.5 cm seems only to need control in three
year intervals, while 3.5–4 cm sized AAA need controlsome money are not used for prevention, they are
not placed in the bank for discounting but used for every second year, and 4–5 cm sized AAA each year.16
But is the indication of treatment clear? The size ofsomething else. Consequently, by adding discounting,
non-existing costs are added. In addition, we were not AAA is the only constantly mentioned prognostic
indicator of rupture. The U.K. Small Aneurysm Trial36analysing several years but only five years in a period
with a very low discount. If the absolute maximal in U.K. and the similar ADAM study in USA have
both randomised more than 1000 AAA sized 4–5.5 cmdiscount was included as 5.6 mill. DKK for 5.1 years at
3% discount per annum, the costs per prevented hospital to early surgery or watchful waiting. No differences
in AAA-related mortality was noticed after five years.death would be 167 000 DKK compared with 117,000
DKr per operation because of ruptured AAA with a However, due to the strong size related risk of rupture,
the smallest AAA must have drawn the results towardsmortality of about 50%. The costs per estimated saved
living year would be 9255 DKK – still quite modest watchful waiting, while the largest AAA must have
drawn the conclusion towards early surgery. Since theexpenses compared with other screening activities.
Before screening can be recommended we must be risk of rupture increases exponential with increasing
size, the optimal size cut-point seems theoreticallysure that we have an acceptable treatment, with clear
indications. Survivors are living with the same quality to lie in the upper half of the examined interval
(4.8–5.5 cm). No matter which cut-point are chosen,of life as the population of the same age15 but tends
lower survival, and only three (3.5%) have refused the there will still be AAA rupturing during conservative
treatment and people dying of the operation for anoffer of an operation. However, only 60 of 87 (70%)
were operated but 7 of the remaining are waiting for AAA which never would have ruptured. This ethical
problem is serious but at present insoluble.the operation, and 5 are not excluded from operative
treatment. Consequently, it is 17% that have con- Nevertheless, the costs, the problems with psy-
chological side effects of having a small AAA diag-traindications for operation or refuses treatment. How-
ever, 85–90% of the AAA diagnosed at screening are nosed, and the minor differences in the indication
of operation seems not to outweigh the benefits oftoo small to be recommended operation. The con-
sequently non-operative observation are reported to screening.
In all, our earlier and present results seems to pointcause decreased health-related, global and generic
quality of life.15,27 However, half of these patients will to the fact that screening 65 year-old men for AAA in
Denmark can safely be advocated.become operated within five years, and models to
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